mTOR Inhibition for Cancer Therapy: Past, Present and Future
This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs.
Stellaris LM4F120 and Tiva C Series LaunchPad is great products based ARM Cortex-M for learning. This book helps you to get started with Stellaris LM4F120 and Tiva C Series LaunchPad and how to build programs using Energia and Code Composer Studio. The following is highlight topics: * Preparing Development Environment * Developing…
Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compounds currently under evaluation.
How to download book
Buy this book
You can buy this book now only for $115.99. This is the lowest price for this book.
Download book free
If you want to download this book for free, please register, approve your account and get one book for free.
After that you may download book «mTOR Inhibition for Cancer Therapy: Past, Present and Future»: